• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these drugs could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental conditions like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take best adhd medication for adults with anxiety medication must consider the benefits of taking it against the potential risks to the foetus. The doctors don't have the information to provide clear recommendations however they can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case control study to examine the prevalence of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was correct and to reduce any bias.

The research conducted by the researchers was not without limitations. The researchers were not able in the beginning, to separate the effects of the medication from the disorder. This limitation makes it difficult to know whether the small associations observed in the groups that were exposed are due to the use of medication or comorbidities that cause confusion. In addition the researchers did not examine the long-term outcomes of offspring.

The study did reveal that infants whose mothers had taken online adhd medication medications during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a child with a low Apgar score (less than 7). These risks did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medication during pregnancies in the early stages can be offset by greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when possible, assist them in developing strategies to improve coping skills that can lessen the impact of her disorder on her daily functioning and relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether to continue or discontinue treatment during pregnancy is a question that doctors are having to confront. The majority of these decisions are taken in the absence of solid and reliable evidence regardless, so doctors must weigh their knowledge about their experiences, the experiences of other doctors, and what the research suggests about the subject as well as their own judgments for each individual patient.

Particularly, the subject of potential risks for the baby can be a challenge. The research that has been conducted on this topic is based on observations rather than controlled studies, and many of the findings are contradictory. Furthermore, most studies restrict their analysis to live births, which could underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these limitations by analyzing both data on live and deceased births.

The conclusion: While some studies have found that there is a positive correlation between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship, and most studies show a neutral or even slightly negative impact. As a result, a careful risk/benefit assessment must be done in each instance.

It can be difficult, if not impossible, for women suffering from ADHD to stop taking their medication. In an article published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. Furthermore, a loss of medication may affect the ability to complete jobs and drive safely which are essential aspects of daily life for many people suffering from ADHD.

She suggests that women who are unsure whether to continue taking the medication or stop due to pregnancy should educate family members, coworkers and acquaintances about the condition, the impact on daily functioning and the benefits of keeping the current treatment. In addition, educating them can aid in ensuring that the woman feels supported when she is struggling with her decision. Some medications can i get adhd meds without a diagnosis pass through the placenta. If a woman decides not to take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her baby.

Risk of Birth Defects

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing as does the concern about the potential effects of these drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers used two massive data sets to examine over 4.3 million pregnant women and determine if stimulant medication use increased the risk of birth defects. Researchers found that while the overall risk is low, the first trimester ADHD Best medication for anxiety depression And adhd exposure was associated with slightly higher rates of certain heart defects, such as ventriculoseptal defect.

The authors of the study didn't find any association between the use of early medications and congenital anomalies such as facial deformities or club feet. The findings are in line with previous studies that have shown a small but significant increase in the risk of heart malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk was higher during the latter part of pregnancy, when many women decide to stop taking their ADHD medication.

Women who took ADHD medications during the first trimester of their pregnancies were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby who required help breathing at birth. However, the authors of the study were unable to eliminate bias due to selection by limiting the study to women who did not have other medical issues that could have contributed to these findings.

Researchers hope their research will help doctors when they meet pregnant women. The researchers recommend that, while discussing benefits and risks are crucial, the decision on whether to continue or stop medication should be based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also advise that while discontinuing the medications is an option, it is not an option to consider due to the high rate of depression and other mental health problems for women who are expecting or postpartum. Additionally, the research suggests that women who choose to stop taking their medication are more likely to have a difficult time getting used to life without them following the birth of their baby.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with ADHD who have to manage their symptoms while attending doctor appointments and preparing for the arrival of a child and getting used to new routines at home are often faced with a number of difficulties. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications pass through breast milk in low amounts, therefore the risk for breastfeeding infant is minimal. However, the rate of exposure to medication by the infant can differ based on dosage, frequency it is taken and the time of day it is administered. In addition, different drugs enter the infant's system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't fully understood.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant medications during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefit of continuing her medication against the possible risks to the fetus. As long as there is no more information, GPs should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal period.

A growing number of studies have shown that most women can safely continue taking their adhd sleep medication medication during pregnancy and while breastfeeding. As a result, more and more patients choose to do so and in consultation with their physician, they have discovered that the benefits of keeping their current medication exceed any risk.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor, and the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also needed to help pregnant women with ADHD recognize the signs and underlying disorder. They should also learn about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. The pregnancy counselling should consist of discussion of a management plan for both mother and child, and monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.